Literature DB >> 21612287

Interaction between lipids and antimicrobial oligomers studied by solid-state NMR.

Weiguo Hu1, Abhigyan Som, Gregory N Tew.   

Abstract

Antimicrobial peptides and their synthetic analogues are well known to interact with the cell membrane, which has complex distributions of lipids. The phase behavior of DOPE/DOPG mixed lipids and the interaction between the lipids and several synthetic amphiphilic antimicrobial oligomers (AMOs) were studied by solid-state nuclear magnetic resonance (NMR). A phase diagram of the lipids over a broad window of water content was constructed. There are large areas in the phase diagram where multiple phases coexist, and the fraction of each phase at a given state is dependent on the sample's preparation and thermal history. The comparable stability of the different phases implies that even slight changes in the lipid condition could result in substantial changes to the phase structure, which may be utilized by living organisms to achieve many membrane functions. Nuclear Overhauser spectroscopy (NOESY) and several other NMR experiments indicated that the AMO primarily resides in the head group region of the lipids and that DOPE, the negative intrinsic curvature lipid, does not selectively enrich in the inverted hexagonal phase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612287      PMCID: PMC3810013          DOI: 10.1021/jp202414m

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  27 in total

1.  Non-haemolytic beta-amino-acid oligomers.

Authors:  E A Porter; X Wang; H S Lee; B Weisblum; S H Gellman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  De novo design, synthesis, and characterization of antimicrobial beta-peptides.

Authors:  D Liu; W F DeGrado
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

3.  Orientation, dynamics, and lipid interaction of an antimicrobial arylamide investigated by 19F and 31P solid-state NMR spectroscopy.

Authors:  Yongchao Su; William F DeGrado; Mei Hong
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

4.  Tryptophan-anchored transmembrane peptides promote formation of nonlamellar phases in phosphatidylethanolamine model membranes in a mismatch-dependent manner.

Authors:  P C van der Wel; T Pott; S Morein; D V Greathouse; R E Koeppe; J A Killian
Journal:  Biochemistry       Date:  2000-03-21       Impact factor: 3.162

5.  The effect of dimethyl sulphoxide on the structure and phase behaviour of palmitoleoylphosphatidylethanolamine.

Authors:  Z W Yu; P J Quinn
Journal:  Biochim Biophys Acta       Date:  2000-12-20

6.  De novo design of biomimetic antimicrobial polymers.

Authors:  Gregory N Tew; Dahui Liu; Bin Chen; Robert J Doerksen; Justin Kaplan; Patrick J Carroll; Michael L Klein; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  Polymorphism of phosphatidylglycerol-phosphatidylethanolamine model membrane systems: a 31p NMR study.

Authors:  S B Farren; P R Cullis
Journal:  Biochem Biophys Res Commun       Date:  1980-11-17       Impact factor: 3.575

8.  De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications.

Authors:  Gregory N Tew; Richard W Scott; Michael L Klein; William F Degrado
Journal:  Acc Chem Res       Date:  2010-01-19       Impact factor: 22.384

Review 9.  Lipid polymorphism and the functional roles of lipids in biological membranes.

Authors:  P R Cullis; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1979-12-20

10.  Multi-dimensional pulsed field gradient magic angle spinning NMR experiments on membranes.

Authors:  Holly C Gaede; Klaus Gawrisch
Journal:  Magn Reson Chem       Date:  2004-02       Impact factor: 2.447

View more
  1 in total

1.  Designing mimics of membrane active proteins.

Authors:  Federica Sgolastra; Brittany M Deronde; Joel M Sarapas; Abhigyan Som; Gregory N Tew
Journal:  Acc Chem Res       Date:  2013-09-05       Impact factor: 22.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.